Cough Drug Ambroxol Tested as Parkinson's Treatment in Trial
The Phase III trial will enroll over 300 people with Parkinson's disease, some of whom will receive the cough drug ambroxol.
Source: gizmodo.com
Stay updated with breaking news from Scientists Are Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Phase III trial will enroll over 300 people with Parkinson's disease, some of whom will receive the cough drug ambroxol.